Is there still a role for peripheral parenteral nutrition?

Nutrition in Clinical Practice

Volumn 24, Issue 6, 2009, Pages 709-717

  Gura, Kathleen M ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Fat emulsions; Infusions; Intravenous; Parenteral nutrition; Total; Veins

Indexed keywords

AMINO ACID; ELECTROLYTE; GLUCOSE; LIPID EMULSION; MINERAL; VITAMIN;

CENTRAL VENOUS CATHETERIZATION; CHILD CARE; HUMAN; INFUSION SYSTEM; NUTRITIONAL SUPPORT; OSMOLARITY; PH; PHLEBITIS; PRACTICE GUIDELINE; REVIEW; RISK BENEFIT ANALYSIS; TOTAL PARENTERAL NUTRITION; TREATMENT INDICATION; VASCULAR ACCESS;

CATHETERIZATION, PERIPHERAL; EQUIPMENT DESIGN; HUMANS; OSMOLAR CONCENTRATION; PARENTERAL NUTRITION;

EID: 74749096073     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0884533609351318     Document Type: Review

References (94)

1. Brunschwig A, Bigelow RR, Nichols S. Intravenous nutrition for eight weeks: partial enterectomy, recovery. JAMA. 1945;129:441-443.
2. Wilmore DW, Dudrick SJ. Growth and development of an infant receiving all nutrients exclusively by vein. JAMA. 1968;4;203:860-864.
3. Payne-James JJ, De Gara CJ, Grimble GK, Silk DB. Artificial nutrition support in hospitals in the United Kingdom-1994: third national survey. Clin Nutr. 1995;14:329-335.
4. Pittiruti M, Hamilton H, Biffi R, Macfie J, Pertkiewicz M. ESPEN guidelines on parenteral nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr. 2009 May 21. [Epub ahead of print].
5. Earhart A, Jorgensen C, Kaminski D. Assessing pediatric patients for vascular access and sedation. J Infus Nurs. 2007;30:226-231.
6. Campos-Oltra JR, Yunes-Zárraga JL, Villatoro-Méndez C. Analysis of the costs and complications of different procedures for the administration of intravenous liquids. Bol Med Hosp Infant Mex. 1989;46:547-553.
7. Opilla M. Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control. 2008;36:S173.e5-8.
8. Ziegler M, Jakobowski D, Hoelzer D, Eichelberger M, Koop CE. Route of pediatric parenteral nutrition: proposed criteria revision. J Pediatr Surg. 1980;15:472-476.
9. Chan MR, Young HN, Becker YT, Yevzlin AS. Obesity as a predictor of vascular access outcomes: analysis of the USRDS DMMS Wave II study. Semin Dial. 2008;21:274-279.
10. Stovroff M, Teague WG. Intravenous access in infants and children. Pediatr Clin North Am. 1998;45:1373-1393, viii.
11. Food and Drug Administration Task Force. Precautions necessary with central venous catheters. FDA Drug Bull. July 1989:15-16.
12. Scott WL. Central venous catheters: an overview of Food and Drug Administration activities. Surg Oncol Clin North Am. 1995;4:377-392.
13. Canaud B, Desmeules S, Klouche K, Leray-Moragués H, Béraud JJ. Vascular access for dialysis in the intensive care unit. Best Pract Res Clin Anaesthesiol. 2004;18:159-174.
14. Vesely T. Central venous catheter tip position: a continuing controversy. J Vasc Interv Radiol. 2003;14:527-534.
15. Kohlhardt SR, Smith RC. Fine-bore silicone catheters for peripheral intravenous nutrition in adults. Br Med J. 1989;229:1380.
16. Madan M, Alexander DJ, McMahon MJ. Influence of catheter type on the occurrence of thrombophlebitis during peripheral intravenous nutrition. Lancet. 1992;339:101.
17. Peripherally inserted central catheters. Intravenous Nurses Society. J Intraven Nurs. 1997;20:172-174.
18. Midline and midclavicular catheters. J Intraven Nurs. 1997;20: 175-178.
19. Infusion Nursing Standards of Practice. Infusion Nurses Society. J Infus Nurs. 2006;29(1 suppl):S1-S92.
20. Pearson ML. The Hospital Infection Control Practices Advisory Committee. Guidelines for prevention of intravascular-device related infections. Infect Control Hosp Epidemiol. 1995;17:438-473.
21. Homer LD, Holmes KR. Risks associated with 72- and 96-hour peripheral intravenous catheter dwell times. J Intraven Nurs. 1998;21:301-305.
22. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters: a randomized controlled trial. Ann Int Med. 1991;114:845-853.
23. Powell J, Tarnow KG, Perucca R. The relationship between peripheral intravenous catheter indwell time and the incidence of phlebitis. J Infus Nurs. 2008;31:39-45.
24. Johansson ME, Pilhammar E, Khalaf A, Willman A. Registered nurses' adherence to clinical guidelines regarding peripheral venous catheters: a structured observational study. Worldviews Evid Based Nurs. 2008;5:148-159.
25. London NJ, Nash R. ABC of arterial and venous disease: varicose veins. BMJ. 2000;20;320:1391-1394.
26. Whitson M. Intravenous therapy in the older adult: special needs and considerations. J Intraven Nurs. 1996;19:251-255.
27. Lavery I, Smith E. Peripheral vascular access devices: risk prevention and management. Br J Nurs. 2007;16:1378, 1380, 1382-1383.
28. Jackson A. Infection control-a battle in vein: infusion phlebitis. Nurs Times. 1998;94:68, 71.
29. Midline and midclavicular catheters. Infusion Nurses Society. J Intravenous Nurs. 1997;20:175-178.
30. Griffiths V. Midline catheters: indications, complications and maintenance. Nurs Strand. 2007;21;22:48-57.
31. Anderson NR. Midline catheters: the middle ground of intravenous therapy administration. J Infus Nurs. 2004;27:313-321.
32. Matsumoto M, Shirotani N, Kameoka S. Clinical study on the ratio of glucose/fat in peripheral parenteral nutrition and the usage of a midline catheter. Surg Today. 1999;29:1040-1046.
33. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R; Parenteral Nutrition Guidelines Working Group; European Society for Clinical Nutrition and Metabolism; European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Society of Paediatric Research (ESPR). Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005;41(suppl 2):S1-S87.
34. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, U.S. Pediatrics. 2002;110:e51.
35. Gupta A, Mehta Y, Juneja R, Trehan N. The effect of cannula material on the incidence of peripheral venous thrombophlebitis. Anaesthesia. 2007;62:1139-1142.
36. Payne-James JP, Khawaga HT. First choice for total parenteral nutrition: the peripheral route. JPEN J Parenter Enteral Nutr. 1992;17:468.
37. May J, Murchan P, MacFie J, et al. Prospective study of aetiology of infusion phlebitis and line failure during peripheral parenteral nutrition. Br J Surg. 1996;83:1091.
38. Kohlhardt SR, Smith RC, Wright CR, Sucic KA. Fine-bore peripheral catheters versus central venous catheters for delivery of intravenous nutrition. Nutrition. 1992;8:412-417.
39. Plusa SM, Horsman R, Kendall-Smith S, Webster N, Primrose JN. Fine-bore cannulas for peripheral intravenous nutrition: polyurethane or silicone? Ann R Coll Surg Engl. 1998;80:154-156.
40. Linder LE, Curelaru I, Gustavsson B, Hansson HA, Stenqvist O, Wojciechowski J. Material thrombogenicity in central venous catheterization: a comparison between soft, antebrachial catheters of silicone elastomer and polyurethane. JPEN J Parenter Enteral Nutr. 1984;8:399-406. (Pubitemid 14090267)
41. Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest. 2000;117:178-183.
42. Brandt CT. Phlebitis due to venous catheters: causes and occurrence. Ugeskr Laeger. 2000;162:4531-4534.
43. Stovroff M, Teague WG. Intravenous access in infants and children. Pediatr Clin North Am. 1998;45:1373-1393, viii
44. Henriques V, Anderson AC. Uber parenterale Emahrung durch intravenose Injektivnen. Physiol Chem. 1913;88:357-369.
45. Kuwahara T, Asanami S, Tamura T, Kubo T. Dilution is effective in reducing infusion phlebitis in peripheral parenteral nutrition: experimental study in rabbits. Nutrition. 1998;14:186.
46. Gazitua R, Wilson K, Bistrian BR, Blackburn GL. Factors determining peripheral vein tolerance to amino acid infusions. Arch Surg. 1979;114:897-900.
47. American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26:1SA-138SA.
48. Isaacs JW, Millikan WJ, Stackhouse J, Hersh T, Rudman D. Parenteral nutrition of adults with a 900 milliosmolar solution via peripheral veins. Am J Clin Nutr. 1977;30:552-559.
49. Hoheim DF, O'Callaghan TA, Joswiak BJ, et al. Clinical experience with three-in-one admixtures administered peripherally. Nutr Clin Pract. 1990;5:118-122.
50. Pereira-Silva L, Virella D, Henriques G, Rebelo M, Serelha M, Videira-Amaral JM. A simple equation to estimate the osmolarity of neonatal parenteral nutrition solutions. JPEN J Parenter Enteral Nutr. 2004;28:34-37.
51. Kane KF, Cologiovanni L, McKiernan J, et al. High osmolality feedings do not increase the incidence of thrombophlebitis during peripheral i.v. nutrition. JPEN J Parenter Enteral Nutr. 1996;20:194-197.
52. American Society for Parenteral and Enteral Nutrition. The A.S.P.E.N. Nutrition Support Practice Manual. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 1998.
53. Pineault M, Chessex P, Piedboeuf B, Bisaillon S. Beneficial effect of coinfusing a lipid emulsion on venous patency. JPEN J Parenter Enteral Nutr. 1989;13:637-640.
54. Driscoll DF. Total nutrient admixtures: theory and practice. Nutr Clin Pract. 1995;10:114-119.
55. Li LC, Sampogna TP. A factorial design study on the physical stability of 3-in-1 admixtures. J Pharm Pharmacol. 1993;45:985-987.
56. Kruse JA, Clark VL, Carlson RW, Geheb MA. Concentrated potassium chloride infusions in critically ill patients with hypokalemia. J Clin Pharmacol. 1994;34:1077-1082.
57. Pucino F, Danielson BD, Carlson JD, et al. Patient tolerance to intravenous potassium chloride with and without lidocaine. Drug Intell Clin Pharm. 1988;22:676-679.
58. Agarwal A, Arora A, Sonohata M. Iatrogenic calcinosis cutis following extravasation of calcium gluconate. J Orthop Sci. 2008;13:576-577.
59. Moss J, Syrengelas A, Antaya R, Lazova R. Calcinosis cutis: a complication of intravenous administration of calcium glucanate. J Cutan Pathol. 2006;33(suppl 2):60-62.
60. Kuwahara T, Asanami S, Tamura T, Kaneda S. Effects of pH and osmolality on phlebitic potential of infusion solutions for peripheral parenteral nutrition. J Toxicol Sci. 1998;23:77-85.
61. Horowitz B, Rowe AW, Stryker MH, et al. Biochemistry of whole blood in poly(ethylene-co-ethylacrylate) experimental blood containers. Vox Sang. 1985;48:143-149.
62. Fonkalsrud EW, Carpenter K, Masuda Y, Beckerman JH. Prophylaxis against post infusion phlebitis. Surg Gynecol Obstetr. 1971;133:253-256.
63. Hessov I, Bojsen-Muller M. Experimental infusion thrombophlebitis: importance of the infusion rates. Eur J Intensive Care Med. 1976;2:103.
64. Kuwahara T, Asanami S, Kubo S. Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition. 1998;14:496-501.
65. Nordenstrom J. Peripheral parenteral nutrition: changing trend in intravenous feeding. Nutrition. 1992;8:440-441.
66. Nordenström J, Jeppsson B, Lovén L, Larsson J. Peripheral parenteral nutrition: effect of a standardized compounded mixture on infusion phlebitis. Br J Surg. 1991;78:1391-1394.
67. Suarez T, Baerwald JP, Kraus C. Central venous access: the effects of approach, position, and head rotation on internal jugular vein cross-sectional area. Anesth Analg. 2002;95:1519-1524.
68. Chaturvedi A, Bithal PK, Dash H, Chauhan RS, Mohanty B. Catheter malplacement during central venous cannulation through arm veins in pediatric patients. J Neurosurg Anesthesiol. 2003;15:170-175.
69. Karapinar B, Cura A. Complications of central venous catheterization in critically ill children. Pediatr Int. 2007;49:593-599.
70. Uslusoy E, Mete S. Predisposing factors to phlebitis in patients with peripheral intravenous catheters: a descriptive study. J Am Acad Nurse Pract. 2008;20:172-180.
71. Horne MK III, Merryman PK, Mayo DJ, Gralnick HR, Chang RC, Alexander HR. Reductions in tissue plasminogen activator and thrombomodulin in blood draining veins damaged by venous access devices. Thromb Res. 1995;15;79:369-376.
72. Fullilove S, Fixsen J. Major limb deformities as complications of vascular access in neonates. Paediatr Anaesth. 1997;7:247-250.
73. Kumar RJ, Pegg SP, Kimble RM. Management of extravasation injuries. ANZ J Surg. 2001;71:285-289.
74. Hecker JF. Potential for extending survival of peripheral intravenous infusions. Br Med J. 1992;304:619-624.
75. Bier ID. Peripheral intravenous nutrition therapy: outpatient, office-based administration. Altern Med Rev. 2000;5:347-354.
76. Ball PA. Intravenous in-line filters: filtering the evidence. Curr Opin Clin Nutr Metab Care. 2003;6:319-325.
77. McKinnon BT. FDA safety alert: hazards of precipitation associated with parenteral nutrition. Nutr Clin Pract. 1996;11:59-65.
78. Mirtallo J, Canada T, Johnson D, et al. Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004;28:S39-S70.
79. Bayer-Berger M, Chioléro R, Freeman J, Hirschi B. Incidence of phlebitis in peripheral parenteral nutrition: effect of the different nutrient solutions. Clin Nutr. 1989;8:181-186.
80. Haumont D, Richelle M, Deckelbaum RJ, Coussaert E, Carpentier YA. Effect of liposomal content of lipid emulsions on plasma lipid concentrations in low birth weight infants receiving parenteral nutrition. J Pediatr. 1992;121(5 pt 1):759-763.
81. Sacks GS, Driscoll DF. Does lipid hang time make a difference? Time is of the essence. Nutr Clin Pract. 2002;17:284-290.
82. Kuwahara T, Asanami S, Tamura T, Kaneda S. Effects of pH and osmolality on phlebitic potential of infusion solutions for peripheral parenteral nutrition. J Toxicol Sci. 1998;23:77-85.
83. Henann NE, Jacks TT. Compatibility and availability of sodium bicarbonate in total parenteral nutrient solutions. Am J Hosp Pharm. 1985;42:2718-2720.
84. Niemiec PW Jr, Vanderven TW. Compatibility considerations in parenteral nutrient solutions. Am J Hosp Pharm. 1984;41:893-911.
85. Tighe MJ, Wong C, Martin IG, McMahon MJ. Do heparin, hydrocortisone, and glyceryl trinitrate influence thrombophlebitis during full intravenous nutrition via a peripheral vein? JPEN J Parenter Enteral Nutr. 1995;19:507-509.
86. Roongpisuthipong C, Puchaiwatananon O, Songchitsomboon S, Kanjanapanjapol S. Hydrocortisone, heparin, and peripheral intravenous infusion. Nutrition. 1994;10:211-213.
87. Silvers KM, Winterbourn CC. The destabilisation of total parenteral nutrition by heparin: how real is the problem? N Z Med J. 1997;110:386.
88. Gitau MM, Arora N. Heparin-induced thrombocytopenia. Mo Med. 2009;106:50-54.
89. Khawaja HT, Williams JD, Weaver PC. Transdermal glyceryl trinitrate to allow peripheral total parenteral nutrition: a double-blind placebo controlled feasibility study. J R Soc Med. 1991;84:69-72.
90. Tighe MJ, Wong C, Martin IG, McMahon MJ. Do heparin, hydrocortisone, and glyceryl trinitrate influence thrombophlebitis during full intravenous nutrition via a peripheral vein? JPEN J Parenter Enteral Nutr. 1995;19:507-509.
91. Dobbins BM, Catton JA, Tighe MJ, et al. Randomized clinical trials to determine the role of topical glyceryl trinitrate in peripheral intravenous nutrition. Br J Surg. 2003;90:804-810.
92. Tjon JA, Ansani NT. Transdermal nitroglycerin for the prevention of intravenous infusion failure due to phlebitis and extravasation. Ann Pharmacother. 2000;34:1189-1192.
93. Yucha CB, Russ P, Baker S. Detecting i.v. infiltrations using a venoscope. J Intraven Nurs. 1997;20:50-55.
94. Schears GJ. Summary of product trials for 10,164 patients: comparing an intravenous stabilizing device to tape. J Infus Nurs. 2006;29: 225-231.